Clicky

Sequana Medical NV(SEQUA)

Description: Sequana Medical NV, a commercial stage medical device company, engages in the development of platform for the treatment of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; Direct Sodium Removal (DSR) for the treatment of persistent congestion due to heart failure; and alfapump DSR, a fully implanted system for direct sodium removal therapy in patients with fluid overload due to heart failure. It operates in Belgium, Germany, France, Switzerland, and internationally. The company was founded in 2006 and is headquartered in Ghent, Belgium.


Keywords: Medicine Heart Failure Liver Disease Heart Hepatorenal Syndrome Ascites Hypervolemia

Home Page: www.sequanamedical.com

Kortrijksesteenweg 1112
Gent, 9051
Belgium
Phone: 32 9 298 28 28


Officers

Name Title
Mr. Ian Crosbie CEO & Exec. Director
Ms. Kirsten Van Bockstaele Chief Financial Officer
Ms. Lies Vanneste Director of Investor Relations
Mr. Gijs Klarenbeek Chief Medical Officer
Mr. Martijn Blom Chief Commercial Officer
Dr. Oliver Godje M.D., Ph.D. Chief Medical Officer

Exchange: BR

Country: BE

Currency: Euro (€)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 11.5189
Price-to-Sales TTM: 182.3852
IPO Date:
Fiscal Year End: December
Full Time Employees: 60
Back to stocks